Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE MRSA infections were classified as either community-associated (CA-MRSA) or healthcare-associated (HA-MRSA), with HA-MRSA further classified as hospital-onset (HAHO-MRSA) or community-onset (HACO-MRSA) according to standard epidemiological definitions established by the U.S. Centers for Disease Control and Prevention (CDC). 22745670 2012
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE The results indicated that the recent CA-MRSA found in Chinese children with CAP was largely associated with the spread of the ST59-MRSA-IV clone, and most of the PVL-positive strains in this study did not cause necrotic cases. 20232474 2010
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE From 2004, the MRSA genetic background became more diverse, and in 2006, ST5-MRSA-IV was only sporadically observed. 19130105 2009
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Community-associated MRSA and livestock-associated MRSA, belonging to ST59 and ST9, respectively, were identified in both humans and pigs. 29377579 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE It is important to note that the most common site of CA-MRSA infection in inpatients was the respiratory tract; respiratory infections with CA-MRSA frequently cause severe infectious diseases. 22446128 2012
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE 44 isolates were Oceania strain (ST30-MRSA-IV), 20 were Queensland strain (ST93-MRSA-IV), ten were UK EMRSA-15 (ST22-MRSA-IV), eight were WA MRSA-1 (ST1-MRSA-IV), two were WA MRSA-5 (ST8-MRSA-IV), one was WA MRSA-2 (ST78slv-MRSA-IV), one was WA MRSA-15 (ST59-MRSA-IV), and the remainder were sporadics. 18038318 2008
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA, respectively) in the nostrils of dogs and workers at an animal shelter were cultured. 30924987 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE We formulated and analyse a mathematical model to characterise the transmission co-dynamics of hospital-acquired MRSE (HA-MRSA) and community-acquired MRSE (CA-MRSA) and to investigate the long run competitiveness of the two strains in hospital. 29953912 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Dissemination of multiple MRSA clones among community-associated methicillin-resistant Staphylococcus aureus infections from Japanese children with impetigo. 21327935 2011
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Defining CA-MRSA by the absence of risk factors for healthcare exposure greatly underestimates the burden of epidemic CA-MRSA disease. 18422435 2008
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Detection rate of MRSA in our study shows the necessity to improve in healthcare practices and to formulate new policy for the control of MRSA infections. 28693489 2017
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE Using a novel model of MRSA population-based surveillance, sociodemographic risk associations, yearly geospatial dissemination and prevalence of CA-MRSA infections over an 11 year period was identified in an urban healthcare jurisdiction of Calgary. 31288765 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE One hundred seventy-seven targeted metabolites from over 20 metabolic pathways were specifically screened and one hundred and thirty metabolites from in vitro bacterial tests were confidently detected from both methicillin susceptible and methicillin resistant Staphylococcus aureus (MSSA and MRSA, respectively). 27316783 2017
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Delafloxacin is an oral or intravenous (IV) antibiotic indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI), including both gram-positive (including methicillin-resistant Staphylococcus aureus [MRSA]) and gram-negative organisms. 30957167 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Among a total of 818 MRSA isolates, we identified ten isolates of PVL-positive ST8-MRSA (USA300) (3 from Hospital D, 4 from Hospital G, and 3 from Hospital A), all of which involved exclusively healthcare-associated (5 isolates) and hospital-acquired bacteraemia (5 isolates). 27209287 2016
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE This technique allows for molecular classification into CA-MRSA (POT-CA) and hospital-associated (HA-) MRSA (POT-HA) with clonal discrimination. 26271590 2015
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Nasal colonization with methicillin-resistant Staphylococcus aureus in the community is being increasingly reported, but there is a general lack of data on MRSA colonization in children in chronic care institutions and on colonization rates in Israeli children. 14689750 2003
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE However, previous studies have not thoroughly investigated whether HA-MRSA-CO has characteristics resembling those of CA-MRSA or hospital-onset, healthcare-associated MRSA (HA-MRSA-HO) infection. 24961181 2014
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Community-associated methicillin-resistant Staphylococcus aureus clonal complex 80 type IV (CC80-MRSA-IV) isolated from the Middle East: a heterogeneous expanding clonal lineage. 25078407 2014
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE The identification of a high percentage of MRSA and presence of VRSA and VISA isolates is a serious warning about the treatment of future MRSA infections and reveals the need for new and effective therapeutic agents. 30811005 2019
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE Methicillin-resistant Staphylococcus aureus/pseudintermedius (MRSA/MRSP), Enterobacteriaceae, and Pseudomonas species (spp.) were characterized. 30332336 2018
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE This result indicates that CA-MRSA isolates in Chinese children are largely associated with the ST59-MRSA-IV clone, and that the predominant clones of CA-MRSA are spread all over the country. 20132304 2010
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE This review focuses on the clinical significance of MRSA infections and new approaches for the laboratory diagnosis and epidemiologic typing of MRSA strains. 31523762 2020
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 GeneticVariation disease BEFREE In all regions analyzed, a single genotype prevailed in both CA-MRSA (82%) and HACO-MRSA(57%), which showed pulsed-field-gel electrophoresis-(PFGE)-type-"I", sequence-type-5-(ST5), SCCmec-type-IVa, spa-t311, and was positive for PVL. 22291965 2012
MRSA - Methicillin resistant Staphylococcus aureus infection
0.100 Biomarker disease BEFREE The Panton-Valentine leucocidin (PVL)-encoding genes, lukF and lukS, are prevalent among CA-MRSA strains and have previously been associated with CA-MRSA infections. 16000462 2005